Dec. 18 (Bloomberg) -- Teva Pharmaceutical Industries Ltd., the world’s largest maker of generic drugs, climbed to the highest level in almost five months following an increase in its U.S.-traded stock.
The shares in the Petach-Tikva, Israel-based company rose to the highest level since July 20, gaining 2.8 percent to 162.90 shekels, or the equivalent of $42.89, at the 4:30 p.m. close in Tel Aviv. Teva’s U.S.-traded shares closed at $42.72 on Dec. 16.
Teva has declined 12 percent in Tel Aviv this year.
To contact the reporter on this story: Shoshanna Solomon in Tel Aviv at email@example.com
To contact the editor responsible for this story: Claudia Maedler at firstname.lastname@example.org